ABL Bio (XKRX:298380) Total Assets : ₩140,758 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is ABL Bio Total Assets?

ABL Bio's Total Assets for the quarter that ended in Mar. 2024 was ₩140,758 Mil.

During the past 12 months, ABL Bio's average Total Assets Growth Rate was -14.40% per year. During the past 3 years, the average Total Assets Growth Rate was 44.50% per year. During the past 5 years, the average Total Assets Growth Rate was 58.80% per year.

During the past 8 years, ABL Bio's highest 3-Year average Total Assets Growth Rate was 123.20%. The lowest was 15.90%. And the median was 44.50%.

Total Assets is connected with ROA %. ABL Bio's annualized ROA % for the quarter that ended in Mar. 2024 was -31.83%. Total Assets is also linked to Revenue through Asset Turnover. ABL Bio's Asset Turnover for the quarter that ended in Mar. 2024 was 0.05.

ABL Bio Total Assets Historical Data

The historical data trend for ABL Bio's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Bio Total Assets Chart

ABL Bio Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

142,902.75

99,894.44

65,452.76

185,180.60

160,144.37

ABL Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															202,901.27	187,609.63	174,699.38	160,144.37	140,758.07

ABL Bio Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

ABL Bio's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	74079.11	+	86065.261
	=	160,144

ABL Bio's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	63807.832	+	76950.235
	=	140,758

ABL Bio (XKRX:298380) Total Assets Explanation

Total Assets is connected with ROA %.

ABL Bio's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-47884.436	/	( (160144.372	+	140758.067)	/ 2 )
	=	-47884.436	/	150451.2195
	=	-31.83 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

ABL Bio's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	7937.206	/	( (160144.372	+	140758.067)	/ 2 )
=	7937.206	/	150451.2195
=	0.05

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

ABL Bio Total Assets Related Terms

Thank you for viewing the detailed overview of ABL Bio's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

ABL Bio (XKRX:298380) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABL Bio Inc (XKRX:298380) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

2nd Floor, 16 Daewangpangyo-Ro 712, Beon-Gil, Bundang-Gu, Gyeonggi-do, Seongnam-si, KOR, 13488

Website

https://www.ablbio.com

ABL Bio Inc is a Korean biotech research company. The company is engaged in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline products include ABL001 an Bispecific Antibody, ABL201-205 an Antibody Drug Conjugate, T cell engager, Dual Immune Cell Targeting BsAb an Immuno-Oncology, ABL301 an BBB-Penetrating Bispecific Antibody.

ABL Bio (XKRX:298380) Headlines

No Headlines